Cat.#: BBM-3C-046
Description | Rat Tail Collagen I, 3 mg/mL from Ace Therapeutics is derived from rat tail, which can be prepared as a clear gel to provide a 3D matrix or surface coating on tissue culture plates as a substrate for culturing primary cells such as keratinocytes and hepatocytes. |
Source | Rar tail |
Size | 20 mL |
Form | Liquid |
Sterility | Passed sterility test for bacteria and fungi. Endotoxin level ≤10 EU/mL |
Concentration | 3 mg/mL |
Storage | 2-8°C |
Shipping | Wet ice |
Aplications | Cell culture |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-043 | Collagen from Human Placenta |
Collagen from Human Placenta is used to induce differentiation of endothelial cells and rat pluripotent cells. This product is a lyophilized powder that can be reconstituted at 1 mg/mL in sterile 0.5 M acetic acid, PBS, or water.
|
inquiry |
BBM-3C-030 | Bovine Collagen Type V (Atelocollagen), 1 mg |
Bovine Collagen Type V (Atelocollagen), 1 mg from Ace Therapeutics is purified from bovine placenta.
|
inquiry |
BBM-3C-032 | Human Collagen Type II, 0.1 mg |
Human Collagen Type II, 0.1 mg from Ace Therapeutics is purified from human cartilage.
|
inquiry |
BBM-3C-051 | Human Collagen Type III |
Collagen Type III is found in a variety of conjunctival tissues, including human skin, and the cornea. Human Collagen Type III from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and the product can be used as a coating on tissue culture surfaces to promote cell adhesion and regulate cell behavior.
|
inquiry |
BBM-3C-070 | Cultrex Bovine Collagen I |
Cultrex Bovine Collagen I from Ace Therapeutics is a purified stromal extracellular matrix protein from fetal bovine extensor tendons and is pepsin-treated to remove telopeptides. This product promotes cell adhesion for cell and tissue culture.
|
inquiry |
BBM-3C-023 | Porcine Collagen Type I and III, 10 mg |
Porcine Collagen Type I and III, 10 mg from Ace Therapeutics is purified from pig’s tissue.
Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-052 | Human Collagen Type IV |
Collagen Type IV is a common component of the basement membrane. Human Collagen Type IV from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and the product can be used to regulate cell growth, differentiation, and tissue formation.
|
inquiry |
BBM-3C-062 | Collagens Type Ⅳ |
Collagens Type IV is derived from bovine tissue treated with pepsin. This product does not gel and needs to be mixed with collagen type I-A.
|
inquiry |
BBM-3C-029 | Bovine Collagen Type III, 10 mg |
Bovine Collagen Type III, 10 mg from Ace Therapeutics is purified from bovine (calf ) skin.
Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-064 | Collagen, Type I, from Rat Tail |
The rat tail collagen I provided by Ace Therapeutics is prepared according to the Birkedal-Hansen method through acetic acid extraction, sodium chloride precipitation, and disodium hydrogen phosphate precipitation. This product is derived from a rat tail, dissolved in 0.02M HAc solution, and the purity is greater than 90% as determined by SDS-PAGE, and it is sterile.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.